Anna Kajaste-Rudnitski

14PUBLICATIONS
91CO-AUTHORS
Gene and molecular therapyBiomedical engineering not elsewhere classifiedSequence analysisAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 18, 2025
AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain.

Helena Costa-Verdera, Vasco Meneghini, Zachary Fitzpatrick

|Jan 27, 2025
Correction for Kajaste-Rudnitski et al., "TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-κB-Responsive Long Terminal Repeat Elements".

Anna Kajaste-Rudnitski, Sara S Marelli, Cinzia Pultrone

|Dec 06, 2024
Antiviral immunity lassoed down by excess RNA.

Erika Valeri, Anna Kajaste-Rudnitski

|Jul 02, 2024
A novel STING variant triggers endothelial toxicity and SAVI disease.

Erika Valeri, Sara Breggion, Federica Barzaghi

|Sep 06, 2023
Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors.

Helena Costa-Verdera, Carmen Unzu, Erika Valeri

|May 31, 2023
Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disorders.

Mariasilvia Colantuoni, Raisa Jofra Hernandez, Emanuela Pettinato

Pageof 3

Frequent Collaborators

4 joint publications

Monah Abou-Alezz

3 joint publications

Elisa Vicenzi

3 joint publications

Angelo D'Alessandro

3 joint publications

Ivan Merelli